# US 2021/0259950 A1 · Brightening skin care serums

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0259950 A1
- Document ID: US20210259950A1
- Status: Published application
- Kind: A1
- Application number: 17/302,627
- Filed: 2021-05-07
- Published: 2021-08-26
- Earliest claimed: 2014-06-12
- Assignees: Colorescience, Inc.
- Applicants: Colorescience, Inc.
- Inventors: Patricia McGill Boland; Deborah Eileen Gregg Bouche; John Anthony Garruto; Bethany Ann McCarver
- Web page: https://patentgrep.com/patent/US20210259950A1

## CPC

- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 8/19: containing inorganic ingredients
- A61K 8/27: Zinc; Compounds thereof
- A61K 8/29: Titanium; Compounds thereof
- A61K 8/34: Alcohols
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/416: {Quaternary ammonium compounds (A61K8/35 takes precedence)}
- A61K 8/4926: {having six membered rings}
- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/55: Phosphorus compounds
- A61K 8/602: {Glycosides, e.g. rutin}
- A61K 8/733: {Alginic acid; Salts thereof}
- A61K 8/891: saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K 8/9711: Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
- A61K 8/9717: Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
- A61K 8/9722: Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
- A61K 8/9728: Fungi, e.g. yeasts
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/007: {Preparations for dry skin}
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/43: Pigments; Dyes
- A61K 2800/72: Hypo-allergenic
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Formulations such as serums to treat skin discoloration via a multi-modal approach are provided in some embodiments in which select ingredients work together to effectively brighten skin and treat hyperpigmentation.

## Claims

### Claim 1

A formulation for treating skin discoloration, comprising effective amounts of:
a Bidens pilosa extract;
an acetyl rheum rhaponticum root extract;
a Vitamin E compound; and
a Thermus thermophilus ferment extract,
wherein the formulation is a topical formulation in the form of a serum.

### Claim 2 (depends on 1)

The formulation of claim 1, wherein said formulation further comprises a glycerin.

### Claim 3 (depends on 1)

The formulation of claim 1, wherein the vitamin E compound is a disodium lauriminodipropionate tocopheryl phosphate.

### Claim 4 (depends on 1)

The formulation of claim 1, wherein said formulation is paraben-free.

### Claim 5 (depends on 1)

The formulation of claim 1,
wherein the amount of the Bidens pilosa extract in the formulation is 0.05-5%, and
wherein the amount of the acetyl rheum rhaponticum root extract in the formulation is 0.005-5%.

### Claim 6 (depends on 1)

The formulation of claim 1,
wherein the amount of the Vitamin E compound in the formulation is 0.05-5%, and
wherein the amount of the Thermus thermophilus ferment extract in the formulation is 0.5-10%.

### Claim 7 (depends on 1)

The formulation of claim 1, wherein said formulation further comprises Elaeis Guineensis oil, Gossypium Herbaceum seed oil and Linum Usitatissimum seed oil.

### Claim 8 (depends on 1)

The formulation of claim 1, further comprising a triglyceride.

### Claim 9

A formulation for treating skin discoloration, comprising effective amounts of:
(i) a first anti-melanin agent, wherein said first anti-melanin agent comprises a Bidens pilosa extract;
(ii) a second anti-melanin agent, wherein said second anti-melanin agent comprises a rheum rhaponticum extract; and
(iii) an anti-inflammatory agent, wherein said anti-inflammatory agent comprises a Vitamin E compound;
wherein the formulation is a topical formulation suitable for topical delivery.

### Claim 10 (depends on 9)

The formulation of claim 9, further comprising a Thermus thermophilus ferment extract.

### Claim 11 (depends on 9)

The formulation of claim 9, wherein said formulation further comprises a glycerin.

### Claim 12 (depends on 9)

The formulation of claim 9, wherein the vitamin E compound is a disodium lauriminodipropionate tocopheryl phosphate.

### Claim 13 (depends on 9)

The formulation of claim 9, wherein said formulation is paraben-free.

### Claim 14 (depends on 9)

The formulation of claim 9, wherein the amount of the first anti-melanin agent in the formulation is 0.05-5%, the amount of the second anti-melanin agent in the formulation is 0.005-5%, and the amount of the anti-inflammatory agent in the formulation is 0.05-5%.

### Claim 15 (depends on 9)

The formulation of claim 9, wherein said formulation further comprises Elaeis Guineensis oil, Gossypium Herbaceum seed oil, and Linum Usitatissimum seed oil.

### Claim 16

A formulation for treating skin discoloration, comprising:
a Bidens pilosa extract;
an acetyl rheum rhaponticum root extract;
a Vitamin E compound;
a Thermus thermophilus ferment extract;
glycerin; and
water,
wherein the formulation is a topical formulation.

### Claim 17 (depends on 16)

The formulation of claim 16,
wherein the amount of the Bidens pilosa extract in the formulation is 0.05-5%,
wherein the amount of the acetyl rheum rhaponticum root extract in the formulation is 0.005-5%; and
wherein the amount of the Vitamin E compound in the formulation is 0.05-5%,
wherein the amount of the Thermus thermophilus ferment extract in the formulation is 0.5-10%.

### Claim 18 (depends on 16)

The formulation of claim 16, wherein said formulation further comprises Elaeis Guineensis oil, Gossypium Herbaceum seed oil and Linum Usitatissimum seed oil.

### Claim 19 (depends on 16)

The formulation of claim 16, wherein said formulation is a serum.

### Claim 20 (depends on 16)

The formulation of claim 16, wherein said formulation further comprises a glycerin and a triglyceride.
